Cargando…

Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia

The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaoping, La Rosa, Francisco G., Genova, Elizabeth Erin, Huber, Kendra, Schaack, Jerome, DeGregori, James, Serkova, Natalie J., Li, Yuan, Su, Lih-Jen, Kessler, Elizabeth, Flaig, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776760/
https://www.ncbi.nlm.nih.gov/pubmed/24058630
http://dx.doi.org/10.1371/journal.pone.0074809
_version_ 1782284877386743808
author Yang, Xiaoping
La Rosa, Francisco G.
Genova, Elizabeth Erin
Huber, Kendra
Schaack, Jerome
DeGregori, James
Serkova, Natalie J.
Li, Yuan
Su, Lih-Jen
Kessler, Elizabeth
Flaig, Thomas W.
author_facet Yang, Xiaoping
La Rosa, Francisco G.
Genova, Elizabeth Erin
Huber, Kendra
Schaack, Jerome
DeGregori, James
Serkova, Natalie J.
Li, Yuan
Su, Lih-Jen
Kessler, Elizabeth
Flaig, Thomas W.
author_sort Yang, Xiaoping
collection PubMed
description The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate the effect of intravesical delivery on Cre recombination (Adeno-Cre), we examined activity and expression of β-galactosidase in the bladder of control ROSA transgenic mice. The results confirmed specific recombination as evidenced by β-galactosidase activity in the bladder urothelium of these mice. Then, we administered the same adenovirus into the bladder of double transgenic Kras(LSLG12D/+). p53(fl/fl) mice. The virus solution was held in place by a distal urethral retention suture for 2 hours. To our surprise, there was a rapid development of a spindle-cell tumor with sarcoma characteristics near the suture site, within the pelvic area but outside the urinary track. Since we did not see any detectable β-galactosidase in the area outside of the bladder in the validating (control) experiment, we interpreted that this sarcoma formation was likely due to transduction by Adeno-Cre in the soft tissue of the suture site. To avoid the loss of skin integrity associated with the retention suture, we transitioned to an alternative technique without suture to retain the Adeno-Cre into the bladder cavity. Interestingly, although multiple Adeno-Cre treatments were applied, only urothelial hyperplasia but not carcinogenesis was observed in the subsequent experiments of up to 6 months. In conclusion, we observed that the simultaneous inactivation of p53 and activation of Kras induces quick formation of spindle-cell sarcoma in the soft tissues adjacent to the bladder but slow formation of urothelial hyperplasia inside the bladder. These results strongly suggest that the effect of oncogene regulation to produce either hyperplasia or carcinogenesis greatly depends on the tissue type.
format Online
Article
Text
id pubmed-3776760
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37767602013-09-20 Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia Yang, Xiaoping La Rosa, Francisco G. Genova, Elizabeth Erin Huber, Kendra Schaack, Jerome DeGregori, James Serkova, Natalie J. Li, Yuan Su, Lih-Jen Kessler, Elizabeth Flaig, Thomas W. PLoS One Research Article The development of the Cre recombinase-controlled (Cre/LoxP) technique allows the manipulation of specific tumorigenic genes, temporarily and spatially. Our original intention of this study was to investigate the role of Kras and p53 in the development of urinary bladder cancer. First, to validate the effect of intravesical delivery on Cre recombination (Adeno-Cre), we examined activity and expression of β-galactosidase in the bladder of control ROSA transgenic mice. The results confirmed specific recombination as evidenced by β-galactosidase activity in the bladder urothelium of these mice. Then, we administered the same adenovirus into the bladder of double transgenic Kras(LSLG12D/+). p53(fl/fl) mice. The virus solution was held in place by a distal urethral retention suture for 2 hours. To our surprise, there was a rapid development of a spindle-cell tumor with sarcoma characteristics near the suture site, within the pelvic area but outside the urinary track. Since we did not see any detectable β-galactosidase in the area outside of the bladder in the validating (control) experiment, we interpreted that this sarcoma formation was likely due to transduction by Adeno-Cre in the soft tissue of the suture site. To avoid the loss of skin integrity associated with the retention suture, we transitioned to an alternative technique without suture to retain the Adeno-Cre into the bladder cavity. Interestingly, although multiple Adeno-Cre treatments were applied, only urothelial hyperplasia but not carcinogenesis was observed in the subsequent experiments of up to 6 months. In conclusion, we observed that the simultaneous inactivation of p53 and activation of Kras induces quick formation of spindle-cell sarcoma in the soft tissues adjacent to the bladder but slow formation of urothelial hyperplasia inside the bladder. These results strongly suggest that the effect of oncogene regulation to produce either hyperplasia or carcinogenesis greatly depends on the tissue type. Public Library of Science 2013-09-18 /pmc/articles/PMC3776760/ /pubmed/24058630 http://dx.doi.org/10.1371/journal.pone.0074809 Text en © 2013 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yang, Xiaoping
La Rosa, Francisco G.
Genova, Elizabeth Erin
Huber, Kendra
Schaack, Jerome
DeGregori, James
Serkova, Natalie J.
Li, Yuan
Su, Lih-Jen
Kessler, Elizabeth
Flaig, Thomas W.
Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
title Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
title_full Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
title_fullStr Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
title_full_unstemmed Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
title_short Simultaneous Activation of Kras and Inactivation of p53 Induces Soft Tissue Sarcoma and Bladder Urothelial Hyperplasia
title_sort simultaneous activation of kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776760/
https://www.ncbi.nlm.nih.gov/pubmed/24058630
http://dx.doi.org/10.1371/journal.pone.0074809
work_keys_str_mv AT yangxiaoping simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT larosafranciscog simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT genovaelizabetherin simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT huberkendra simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT schaackjerome simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT degregorijames simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT serkovanataliej simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT liyuan simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT sulihjen simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT kesslerelizabeth simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia
AT flaigthomasw simultaneousactivationofkrasandinactivationofp53inducessofttissuesarcomaandbladderurothelialhyperplasia